Heron Therapeuti (HRTX) earnings · rev $154.9M
These earnings events as JSON? API free 100/dayHeron Therapeuti (HRTX) is a biotechnology company listed on US.
This HRTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported HRTX revenue for 2025-12-31 was $154.9M. Net income was -$20.2M. Revenue was up 7.4% from 2024-12-31 to 2025-12-31. HRTX currently screens at market cap $332.6M.
When the next HRTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 7.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full HRTX research stays on the stock page; the tape stays on the quote page.
HRTX earnings FAQ
What are HRTX's latest revenue and net income?
Latest cached Heron Therapeuti (HRTX) revenue for Dec 31, 2025 was $154.9M. Net income was -$20.2M. Statements: https://lician.com/financials/hrtx
What is HRTX's latest diluted EPS?
Latest cached Heron Therapeuti (HRTX) diluted EPS for Dec 31, 2025 was -$0.12.
What period does the latest HRTX earnings print cover?
The latest cached Heron Therapeuti (HRTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did HRTX revenue change from the prior cached period?
Cached Heron Therapeuti (HRTX) revenue was up 7.4% from $144.3M (Dec 31, 2024) to $154.9M (Dec 31, 2025). Statements: https://lician.com/financials/hrtx
Where are HRTX earnings listed?
Cached earnings facts for Heron Therapeuti (HRTX) are listed at https://lician.com/earnings/hrtx. Statements: https://lician.com/financials/hrtx
Not investment advice.